Pharmacokinetics of d-tubocurarine in patients with thermal injury

J. A J Martyn, R. S. Matteo, D. J. Greenblatt, Philip W. Lebowitz, J. J. Savarese

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

d-Tubocurarine (dTc) requirements are increased following thermal injury. Significant increases in plasma binding only partially account for the altered requirement. To characterize the pharmacokinetic component of the increased requirement, the disposition of dTc was studied in eight patients with burns ranging from 15% to 80% of body surface area and compared with that in six nonburned surgical patients of comparable age and weight. Plasma levels of dTc were measured by radioimmunoassay at multiple times for 24 hours after a single bolus dose. Derived pharmacokinetic parameters were corrected for the predicted (not measured) fraction bound to plasma. The plasma disappearance curve of dTc was explained by linear sum of two or three exponential terms. The unbound central volume of distribution and renal excretion at 24 hours were significantly increased in burned patients (0.11 ± 0.03 L/kg vs 0.057 ± 0.015 L/kg, p < 0.05, 57% ± 7% vs 40% ± 11%, p < 0.05, respectively). On the other hand, comparable elimination halflives (6.5 ± 1.8 hr vs 6.2 ± 1.3 hr, p > 0.05), unbound volume of distribution (0.86 ± 0.2 L/kg vs 0.96 ± 0.5 L/kg, P > 0.05), and intrinsic clearances (1.62 ± 0.6 ml/kg/min vs 1.56 ± 0.4 ml/kg/min, p > 0.05) were present in burned patients and control patients, respectively. Thus, altered kinetics contributes little to the increased doses required. Similar clearances and elimination half-lives in both groups suggest that loss of dTc through burned tissue is minimal.

Original languageEnglish (US)
Pages (from-to)241-246
Number of pages6
JournalAnesthesia and Analgesia
Volume61
Issue number3
StatePublished - 1982
Externally publishedYes

Fingerprint

Tubocurarine
Pharmacokinetics
Hot Temperature
Wounds and Injuries
Body Surface Area
Burns
Radioimmunoassay
Weights and Measures

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Martyn, J. A. J., Matteo, R. S., Greenblatt, D. J., Lebowitz, P. W., & Savarese, J. J. (1982). Pharmacokinetics of d-tubocurarine in patients with thermal injury. Anesthesia and Analgesia, 61(3), 241-246.

Pharmacokinetics of d-tubocurarine in patients with thermal injury. / Martyn, J. A J; Matteo, R. S.; Greenblatt, D. J.; Lebowitz, Philip W.; Savarese, J. J.

In: Anesthesia and Analgesia, Vol. 61, No. 3, 1982, p. 241-246.

Research output: Contribution to journalArticle

Martyn, JAJ, Matteo, RS, Greenblatt, DJ, Lebowitz, PW & Savarese, JJ 1982, 'Pharmacokinetics of d-tubocurarine in patients with thermal injury', Anesthesia and Analgesia, vol. 61, no. 3, pp. 241-246.
Martyn JAJ, Matteo RS, Greenblatt DJ, Lebowitz PW, Savarese JJ. Pharmacokinetics of d-tubocurarine in patients with thermal injury. Anesthesia and Analgesia. 1982;61(3):241-246.
Martyn, J. A J ; Matteo, R. S. ; Greenblatt, D. J. ; Lebowitz, Philip W. ; Savarese, J. J. / Pharmacokinetics of d-tubocurarine in patients with thermal injury. In: Anesthesia and Analgesia. 1982 ; Vol. 61, No. 3. pp. 241-246.
@article{3c10f1652d6447708b952fccf208fb65,
title = "Pharmacokinetics of d-tubocurarine in patients with thermal injury",
abstract = "d-Tubocurarine (dTc) requirements are increased following thermal injury. Significant increases in plasma binding only partially account for the altered requirement. To characterize the pharmacokinetic component of the increased requirement, the disposition of dTc was studied in eight patients with burns ranging from 15{\%} to 80{\%} of body surface area and compared with that in six nonburned surgical patients of comparable age and weight. Plasma levels of dTc were measured by radioimmunoassay at multiple times for 24 hours after a single bolus dose. Derived pharmacokinetic parameters were corrected for the predicted (not measured) fraction bound to plasma. The plasma disappearance curve of dTc was explained by linear sum of two or three exponential terms. The unbound central volume of distribution and renal excretion at 24 hours were significantly increased in burned patients (0.11 ± 0.03 L/kg vs 0.057 ± 0.015 L/kg, p < 0.05, 57{\%} ± 7{\%} vs 40{\%} ± 11{\%}, p < 0.05, respectively). On the other hand, comparable elimination halflives (6.5 ± 1.8 hr vs 6.2 ± 1.3 hr, p > 0.05), unbound volume of distribution (0.86 ± 0.2 L/kg vs 0.96 ± 0.5 L/kg, P > 0.05), and intrinsic clearances (1.62 ± 0.6 ml/kg/min vs 1.56 ± 0.4 ml/kg/min, p > 0.05) were present in burned patients and control patients, respectively. Thus, altered kinetics contributes little to the increased doses required. Similar clearances and elimination half-lives in both groups suggest that loss of dTc through burned tissue is minimal.",
author = "Martyn, {J. A J} and Matteo, {R. S.} and Greenblatt, {D. J.} and Lebowitz, {Philip W.} and Savarese, {J. J.}",
year = "1982",
language = "English (US)",
volume = "61",
pages = "241--246",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Pharmacokinetics of d-tubocurarine in patients with thermal injury

AU - Martyn, J. A J

AU - Matteo, R. S.

AU - Greenblatt, D. J.

AU - Lebowitz, Philip W.

AU - Savarese, J. J.

PY - 1982

Y1 - 1982

N2 - d-Tubocurarine (dTc) requirements are increased following thermal injury. Significant increases in plasma binding only partially account for the altered requirement. To characterize the pharmacokinetic component of the increased requirement, the disposition of dTc was studied in eight patients with burns ranging from 15% to 80% of body surface area and compared with that in six nonburned surgical patients of comparable age and weight. Plasma levels of dTc were measured by radioimmunoassay at multiple times for 24 hours after a single bolus dose. Derived pharmacokinetic parameters were corrected for the predicted (not measured) fraction bound to plasma. The plasma disappearance curve of dTc was explained by linear sum of two or three exponential terms. The unbound central volume of distribution and renal excretion at 24 hours were significantly increased in burned patients (0.11 ± 0.03 L/kg vs 0.057 ± 0.015 L/kg, p < 0.05, 57% ± 7% vs 40% ± 11%, p < 0.05, respectively). On the other hand, comparable elimination halflives (6.5 ± 1.8 hr vs 6.2 ± 1.3 hr, p > 0.05), unbound volume of distribution (0.86 ± 0.2 L/kg vs 0.96 ± 0.5 L/kg, P > 0.05), and intrinsic clearances (1.62 ± 0.6 ml/kg/min vs 1.56 ± 0.4 ml/kg/min, p > 0.05) were present in burned patients and control patients, respectively. Thus, altered kinetics contributes little to the increased doses required. Similar clearances and elimination half-lives in both groups suggest that loss of dTc through burned tissue is minimal.

AB - d-Tubocurarine (dTc) requirements are increased following thermal injury. Significant increases in plasma binding only partially account for the altered requirement. To characterize the pharmacokinetic component of the increased requirement, the disposition of dTc was studied in eight patients with burns ranging from 15% to 80% of body surface area and compared with that in six nonburned surgical patients of comparable age and weight. Plasma levels of dTc were measured by radioimmunoassay at multiple times for 24 hours after a single bolus dose. Derived pharmacokinetic parameters were corrected for the predicted (not measured) fraction bound to plasma. The plasma disappearance curve of dTc was explained by linear sum of two or three exponential terms. The unbound central volume of distribution and renal excretion at 24 hours were significantly increased in burned patients (0.11 ± 0.03 L/kg vs 0.057 ± 0.015 L/kg, p < 0.05, 57% ± 7% vs 40% ± 11%, p < 0.05, respectively). On the other hand, comparable elimination halflives (6.5 ± 1.8 hr vs 6.2 ± 1.3 hr, p > 0.05), unbound volume of distribution (0.86 ± 0.2 L/kg vs 0.96 ± 0.5 L/kg, P > 0.05), and intrinsic clearances (1.62 ± 0.6 ml/kg/min vs 1.56 ± 0.4 ml/kg/min, p > 0.05) were present in burned patients and control patients, respectively. Thus, altered kinetics contributes little to the increased doses required. Similar clearances and elimination half-lives in both groups suggest that loss of dTc through burned tissue is minimal.

UR - http://www.scopus.com/inward/record.url?scp=0020039780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020039780&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 241

EP - 246

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 3

ER -